PSMA1 and non-small cell lung carcinoma: The non-small cell lung cancer cell lines A549 and NCI-H460 treated with PSMA1 siRNA showed a loss of the chymotrypsin-like activity of proteasome and a significant decrease in homologous recombination-mediated repair of I-SceI-induced DNA double strand breaks [6].